Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Fey

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Transplantation|June 1, 1985
Immunoglobulin levels in dogs after total-body irradiation and bone marrow transplantationH M Vriesendorp, R E Halliwell, P M Johnson, et al.
Agents and Actions|August 1, 1987
High-level C5a gene expression and recovery of recombinant human C5a from Escherichia coliK W Mollison, T A Fey, R A Krause, et al.
Journal of Pharmacological and Toxicological Methods|May 22, 1998
Improved methods for transplanting split-heart neonatal cardiac grafts into the ear pinna of mice and ratsT A Fey, R A Krause, G C Hsieh, et al.
Toxicology|May 7, 1998
Nephrotoxicity studies of the immunosuppressants tacrolimus (FK506) and ascomycin in rat modelsK W Mollison, T A Fey, R A Krause, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesisK W Mollison, W Mandecki, E R Zuiderweg, et al.
The Journal of Antibiotics|December 1, 1991
Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. III. Immunosuppressive activities of dunaimycinsN S Burres, U Premachandran, A Frigo, et al.
Agents and Actions. Supplements|January 1, 1991
C5a structural requirements for neutrophil receptor interactionK W Mollison, T A Fey, R A Krause, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Discovery of less nephrotoxic FK506 analogs and determining immunophilin dependence of immunosuppressant nephrotoxicity with a novel single-dose rat cisplatin potentiation assayK W Mollison, T A Fey, R A Krause, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506)Y W Chen, M L Smith, M P Sheets, et al.
The Journal of Investigative Dermatology|May 8, 1999
A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Transplantation|June 1, 1985
Immunoglobulin levels in dogs after total-body irradiation and bone marrow transplantationH M Vriesendorp, R E Halliwell, P M Johnson, et al.
Agents and Actions|August 1, 1987
High-level C5a gene expression and recovery of recombinant human C5a from Escherichia coliK W Mollison, T A Fey, R A Krause, et al.
Journal of Pharmacological and Toxicological Methods|May 22, 1998
Improved methods for transplanting split-heart neonatal cardiac grafts into the ear pinna of mice and ratsT A Fey, R A Krause, G C Hsieh, et al.
Toxicology|May 7, 1998
Nephrotoxicity studies of the immunosuppressants tacrolimus (FK506) and ascomycin in rat modelsK W Mollison, T A Fey, R A Krause, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesisK W Mollison, W Mandecki, E R Zuiderweg, et al.
The Journal of Antibiotics|December 1, 1991
Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. III. Immunosuppressive activities of dunaimycinsN S Burres, U Premachandran, A Frigo, et al.
Agents and Actions. Supplements|January 1, 1991
C5a structural requirements for neutrophil receptor interactionK W Mollison, T A Fey, R A Krause, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Discovery of less nephrotoxic FK506 analogs and determining immunophilin dependence of immunosuppressant nephrotoxicity with a novel single-dose rat cisplatin potentiation assayK W Mollison, T A Fey, R A Krause, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506)Y W Chen, M L Smith, M P Sheets, et al.
The Journal of Investigative Dermatology|May 8, 1999
A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
Pageof 2